This is a routine tax-withholding sale by a director with no discretionary signal. Monitor for any larger discretionary insider sales in the coming weeks, but this filing alone does not warrant a trading response.
Price Chart
Executive Summary
Director Katryn Blake filed a Form 144 to sell 2,240 shares of Twist Bioscience common stock, valued at approximately $275,250. The sale is a tax-withholding transaction tied to the settlement of a vested equity award, not a discretionary portfolio liquidation. Given the small proportional size relative to the company's $8.2B market cap and the tax-motivated nature, this filing carries minimal standalone signal for the stock.
Key Facts
- Director Katryn Blake filed Form 144 to sell 2,240 shares of Twist Bioscience common stock.
- The proposed sale value is approximately $275,250.
- The shares were acquired on 08/05/2026 via Restricted Stock Vesting from the issuer.
- The filing states the sale is to cover a tax obligation from the settlement of a vested equity award distribution.
- The sale is to be executed through Fidelity Brokerage Services LLC.
Financial Impact
Proposed sale of 2,240 shares valued at ~$275,250, representing a negligible fraction of the company's $8.2B market cap.
Risk Factors
- Insider selling could increase if other directors or officers file additional Form 144s.
- The stock's elevated valuation (94% analyst bullish consensus) introduces downside risk if fundamentals disappoint.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-005946 |
| Document: 0001959173-26-005946-index.html | 0001959173-26-005946 |
| Document: 0001959173-26-005946.txt | 0001959173-26-005946 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 21d ago | Insider Cluster | $127.22 $166.99 | ▲ +31.26% | ▲ +31.60% | $187.45 (+47.34%) |
Aug 27, 2026 5w ago | Insider Cluster | $153.10 $128.71 | ▼ −15.93% | ▼ −16.20% | $187.45 (+22.44%) |
Aug 25, 2026 5w ago | Insider Cluster | $151.42 $132.06 | ▼ −12.79% | ▼ −12.25% | $187.45 (+23.79%) |
Aug 21, 2026 6w ago | Insider Cluster | $145.59 $141.38 | ▼ −2.89% | ▼ −3.37% | $187.45 (+28.75%) |
Aug 20, 2026 6w ago | Insider Cluster | $136.23 $153.10 | ▲ +12.38% | ▲ +11.27% | $187.45 (+37.60%) |
Aug 14, 2026 6w ago | Insider Cluster | $124.41 $140.80 | ▲ +13.17% | ▲ +14.36% | $187.45 (+50.67%) |
Aug 14, 2026 6w ago | Insider Cluster | $124.41 $140.80 | ▼ −13.17% | ▼ −14.36% | $187.45 (−50.67%) |
Aug 12, 2026 7w ago | Insider Cluster | $125.29 $136.23 | ▲ +8.73% | ▲ +10.70% | $187.45 (+49.61%) |
Aug 12, 2026 7w ago | 144 | $125.29 $136.23 | ▲ +8.73% | ▲ +10.70% | $187.45 (+49.61%) |
Aug 11, 2026 7w ago | Insider Cluster | $123.12 $116.10 | ▼ −5.70% | ▼ −5.30% | $187.45 (+52.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access